1. Home
  2. IIIN vs DBVT Comparison

IIIN vs DBVT Comparison

Compare IIIN & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

IIIN

Insteel Industries Inc.

HOLD

Current Price

$33.13

Market Cap

609.9M

Sector

Industrials

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$19.02

Market Cap

508.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IIIN
DBVT
Founded
1953
2002
Country
United States
France
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
609.9M
508.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IIIN
DBVT
Price
$33.13
$19.02
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$19.04
AVG Volume (30 Days)
114.8K
439.7K
Earning Date
01-15-2026
10-28-2025
Dividend Yield
3.37%
N/A
EPS Growth
112.14
N/A
EPS
2.10
N/A
Revenue
$647,706,000.00
$5,502,000.00
Revenue This Year
$14.97
$1,768.71
Revenue Next Year
$7.00
$1,028.88
P/E Ratio
$15.82
N/A
Revenue Growth
22.39
N/A
52 Week Low
$22.49
$2.74
52 Week High
$41.64
$21.50

Technical Indicators

Market Signals
Indicator
IIIN
DBVT
Relative Strength Index (RSI) 63.13 72.42
Support Level $31.34 $12.75
Resistance Level $32.24 $21.50
Average True Range (ATR) 0.69 1.13
MACD 0.39 0.72
Stochastic Oscillator 92.04 70.34

Price Performance

Historical Comparison
IIIN
DBVT

About IIIN Insteel Industries Inc.

Insteel Industries Inc produces and sells prestressed concrete strand (PC strand) and welded wire reinforcement (WWR). PC strand, a high-strength seven-wire cable, is used to strengthen precast concrete in structures like bridges, parking decks, and buildings, enabling longer spans and slimmer designs. WWR includes engineered structural mesh for primary reinforcement, concrete pipe reinforcement for drainage and sewage systems, and standard WWR for crack control in residential and light commercial construction. The company serves markets in the United States and internationally, with the majority of revenue generated in the United States.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: